PhRMA taps Brian Toohey to head international advocacy

WASHINGTON — The Pharmaceutical Research and Manufacturers of America on Thursday announced the addition of Brian Toohey as SVP international advocacy, effective July 11. 

 

Toohey is the former president and CEO of the Semiconductor Industry Association, where he oversaw that industry’s federal advocacy, international trade and technology programs. Before joining the SIA, Toohey had been at PhRMA, first as a lead international lobbyist and then as the leader of its international advocacy team. 

 

“As the biopharmaceutical industry develops bold new treatments that save and improve lives, Brian's proven leadership skills and deep experience in international health policy and advocacy will help get these medicines to patients who need them around the world,” PhRMA president and CEO Stephen J. Ubl said. “He has a strong track record of working effectively with international governments, multilateral organizations and global stakeholders to ensure greater patient access to the breakthrough therapies pioneered by PhRMA member companies.”

 

Toohey also serves on the Dept. of Homeland Security’s Science and Technology Advisory Committee, and is an adjunct professor at the Georgetown University School of Foreign Service.